The Role of Gefitinib in Patients with Non-small-cell Lung Cancer in India

BACKGROUND: Gefitinib, an epidermal growth factor receptor-tyrosine kinase inhibitor, represents a new treatment option for patients with advanced non-small-cell lung cancer (NSCLC). We analyzed the data of patients who received Gefitinib for NSCLC in a tertiary care center in South India. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Asmita Anilkumar, Jose, Wesley M, Pavithran, Kicheelath, Triavadi, Ganesan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680839/
https://www.ncbi.nlm.nih.gov/pubmed/23766595
http://dx.doi.org/10.4103/0973-1075.110237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680839/
https://www.ncbi.nlm.nih.gov/pubmed/23766595
http://dx.doi.org/10.4103/0973-1075.110237

Ejemplares similares